Bashir Ssuna
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Bashir Ssuna has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
- Badru Ssekitooleko
Makerere University
4 shared publications Anne Katahoire
Child Health and Development Centre, College of Health Sciences, Makerere University, Kampala, Uganda
3 shared publications- D Namuguzi
College of Health Sciences, Makerere University
3 shared publications - Frank Asiimwe
Mulago National Referral Hospital
3 shared publications - Haruna Muwonge
Department of Physiology, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda
3 shared publications - Hawa Nalwoga
College of Health Sciences, Makerere University
3 shared publications
Latest Publications
- 15 December 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Ultrasonics
- Vol. 73 (2) , 138-152
Automated Placental ROI Selection for Quantitative Ultrasound Analysis Using Boundary-Aware Thresholding
Quantitative ultrasound (QUS) analysis of placental tissue holds significant promise for evaluating pregnancy health and detecting placental pathologies. However, widespread clinical adoption of QUS is limited by the need for manual selection of a proper region of interest (ROI) for the calculation, which increases the analysis time and introduces operator variability. This study presents an automated ROI determination method that uses deep learning segmentation directly on minimally processed raw RF data (along with corresponding B-mode data for comparison) to replace manual ROI selection in placental QUS analysis while also taking advantage of the model’s internal confidence thresholds to reduce inclusion of non-placental tissue near ambiguous tissue boundaries. Using a diverse, multi-national data set of 1084 annotated ultrasound images, the proposed automated ROI model achieved a mean Dice similarity coefficient (DSC) above 0.8 for confidence thresholds between 50% to 75%. At thresholds above 75%, precision improved, but both DSC and recall performance declined, and the amount of placental tissue identified for an accurate QUS calculation fell below the minimum required ROI size. Bland-Altman analysis showed tight agreement between the QUS values derived from ground truth ROIs and automated ROIs up to a 75% confidence threshold, but reduced agreement at higher thresholds, consistent with inferior performance obtained for placental pixel area below the minimum. These findings demonstrate both the feasibility of automated ROI determination and the need for careful consideration of the confidence thresholds when assessing model performance.
- 15 December 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Ultrasonics
- Vol. 73 (2) , 138-152
Automated Placental ROI Selection for Quantitative Ultrasound Analysis Using Boundary-Aware Thresholding
Quantitative ultrasound (QUS) analysis of placental tissue holds significant promise for evaluating pregnancy health and detecting placental pathologies. However, widespread clinical adoption of QUS is limited by the need for manual selection of a proper region of interest (ROI) for the calculation, which increases the analysis time and introduces operator variability. This study presents an automated ROI determination method that uses deep learning segmentation directly on minimally processed raw RF data (along with corresponding B-mode data for comparison) to replace manual ROI selection in placental QUS analysis while also taking advantage of the model’s internal confidence thresholds to reduce inclusion of non-placental tissue near ambiguous tissue boundaries. Using a diverse, multi-national data set of 1084 annotated ultrasound images, the proposed automated ROI model achieved a mean Dice similarity coefficient (DSC) above 0.8 for confidence thresholds between 50% to 75%. At thresholds above 75%, precision improved, but both DSC and recall performance declined, and the amount of placental tissue identified for an accurate QUS calculation fell below the minimum required ROI size. Bland-Altman analysis showed tight agreement between the QUS values derived from ground truth ROIs and automated ROIs up to a 75% confidence threshold, but reduced agreement at higher thresholds, consistent with inferior performance obtained for placental pixel area below the minimum. These findings demonstrate both the feasibility of automated ROI determination and the need for careful consideration of the confidence thresholds when assessing model performance.
- Open Access
Finding the Sweet Spot: Preferences for Effectiveness, Duration, and Side Effects in a Discrete Choice Experiment Among Uganda’s Key Populations
Background: Human immunodeficiency virus (HIV) affects more than 39 million people worldwide, with Uganda ranked 10th among countries with the highest number of cases. As new preventative HIV injectables emerge, it is vital to think about how best to tailor strategies to promote these injectable drugs, like PrEP and vaccines, when available, to the different populations most in need. Discrete choice experiments (DCEs) are economics-derived methods used to determine factors that influence engagement in a certain behavior. Objective: This study used a DCE to determine the preferences for a preventative HIV injectable drugs/vaccines among people at risk of HIV acquisition in urban and peri-urban areas of Uganda. Methods: In June 2024, we implemented a cross-sectional DCE survey in three urban sites in Uganda in English and Luganda. The survey collected information on demographics, HIV risk, vaccine confidence and responses to the 13 injection product choice tasks presented to determine preferences. We used community-based, respondent-driven sampling methods to recruit participants from three key populations: (1) female sex workers; (2) people who identify as lesbian, gay, bisexual or transgender; and (3) young women (18–24 years). We collected the data on tablets using the Sawtooth Lighthouse Studio software (v. 19.15.6), taking into consideration privacy and confidentiality, given the sensitivity of the information and recent governmental policies in Uganda. Data were analyzed using a split-sample mixed logit regression analysis. The study was approved by local ethical regulatory bodies. Results: From the total of 406 participants screened for this study, 376 participants met the eligibility criteria and were included in the final analysis (85 young women, 159 female sex workers, and 132 who identified as lesbian, gay, bisexual or transgender). The average age was 23.7 (SD: 5.7). The majority of participants had received some secondary school or vocational school (202, 53.7%) The attributes that explained the preferences were primarily severe compared to mild side effects (β: −0.69, 95% CI: −0.78, −0.60), a 30% increase in vaccine/drug effectiveness (β: 0.39, 95% CI: 0.34, 0.44), and a 50,000 UGX (or USD ~13.64) increase in cost (β: −0.22, 95% CI: −0.27, −0.17). There were no significant differences between the preferences for different injectable types. The sensitivity analyses suggested potential differences in preferences by the amount of help participants received from research assistants when completing the survey, although not by income level. Conclusions: Side effects had the greatest impact on participants’ preferences for injectable HIV prevention methods, followed closely by effectiveness and cost. It is therefore essential to develop affordable or free prevention options with minimal side effects. Policymakers should focus on reducing the financial barriers to access and emphasize transparent communication about the effectiveness and safety of these injectables in health promotion campaigns to maximize adoption and improve public health outcomes.
Open AccessFinding the Sweet Spot: Preferences for Effectiveness, Duration, and Side Effects in a Discrete Choice Experiment Among Uganda’s Key Populations
Background: Human immunodeficiency virus (HIV) affects more than 39 million people worldwide, with Uganda ranked 10th among countries with the highest number of cases. As new preventative HIV injectables emerge, it is vital to think about how best to tailor strategies to promote these injectable drugs, like PrEP and vaccines, when available, to the different populations most in need. Discrete choice experiments (DCEs) are economics-derived methods used to determine factors that influence engagement in a certain behavior. Objective: This study used a DCE to determine the preferences for a preventative HIV injectable drugs/vaccines among people at risk of HIV acquisition in urban and peri-urban areas of Uganda. Methods: In June 2024, we implemented a cross-sectional DCE survey in three urban sites in Uganda in English and Luganda. The survey collected information on demographics, HIV risk, vaccine confidence and responses to the 13 injection product choice tasks presented to determine preferences. We used community-based, respondent-driven sampling methods to recruit participants from three key populations: (1) female sex workers; (2) people who identify as lesbian, gay, bisexual or transgender; and (3) young women (18–24 years). We collected the data on tablets using the Sawtooth Lighthouse Studio software (v. 19.15.6), taking into consideration privacy and confidentiality, given the sensitivity of the information and recent governmental policies in Uganda. Data were analyzed using a split-sample mixed logit regression analysis. The study was approved by local ethical regulatory bodies. Results: From the total of 406 participants screened for this study, 376 participants met the eligibility criteria and were included in the final analysis (85 young women, 159 female sex workers, and 132 who identified as lesbian, gay, bisexual or transgender). The average age was 23.7 (SD: 5.7). The majority of participants had received some secondary school or vocational school (202, 53.7%) The attributes that explained the preferences were primarily severe compared to mild side effects (β: −0.69, 95% CI: −0.78, −0.60), a 30% increase in vaccine/drug effectiveness (β: 0.39, 95% CI: 0.34, 0.44), and a 50,000 UGX (or USD ~13.64) increase in cost (β: −0.22, 95% CI: −0.27, −0.17). There were no significant differences between the preferences for different injectable types. The sensitivity analyses suggested potential differences in preferences by the amount of help participants received from research assistants when completing the survey, although not by income level. Conclusions: Side effects had the greatest impact on participants’ preferences for injectable HIV prevention methods, followed closely by effectiveness and cost. It is therefore essential to develop affordable or free prevention options with minimal side effects. Policymakers should focus on reducing the financial barriers to access and emphasize transparent communication about the effectiveness and safety of these injectables in health promotion campaigns to maximize adoption and improve public health outcomes.
- Open Access
Somatic mutation profiles of muscle-invasive bladder cancer in Uganda: A cross-sectional study utilising whole-exome sequencing
Background: Muscle-invasive bladder cancer (MIBC) is a significant cause of cancer-related mortality in sub-Saharan Africa, yet its genomic landscape remains poorly characterised. In Uganda, nearly 60% of urothelial carcinoma cases are muscle-invasive (MIUC), with a near-equal sex distribution, in contrast to global trends. We aimed to define the somatic mutational landscape of Ugandan MIUC using whole-exome sequencing (WES). Methods: In this descriptive cross-sectional study, 57 formalin-fixed paraffin-embedded MIUC tissue blocks were consecutively selected. DNA extraction and exome library preparation were performed for all; 47 passed quality control and 33 remained in the final dataset. Sequencing was performed on the Illumina NovaSeq 6000 platform. Reads were aligned to hg19/GRCh37, and variants called using GATK Mutect2 in tumor-only mode with stringent artefact filters. Variants were annotated with COSMIC, ClinVar, REVEL, and classified according to ACMG/AMP guidelines. Eighteen samples were resequenced on the Aviti platform to validate the low frequency of TP53 mutations. Clinical and histopathological data were also reviewed. Results: All patients presented with gross hematuria, with a median age of 56 years; 17/33 (51.5%) were male. Histological variants occurred in 23/33 (69.7%), most commonly the squamous, microcystic, and nested types (each accounting for 5/23; 21.7%). LVI was present in 28/33 (84.8%). A total of 305 coding mutations were identified, averaging 9.2 ± 6.5 per tumor. Squamous and microcystic variants showed the highest burdens (16.4% and 14.4%). At the nucleotide level, 200/331 (60.4%) substitutions were C>T or C>G, consistent with APOBEC mutagenesis. Missense variants predominated (274/305; 89.8%), followed by frameshifts (31/305; 10.2%). PDE4DIP was the most frequent alteration (8/33; 24.2%), although it was not a canonical driver. Canonical recurrent drivers included FGFR3 (18.2%), FOXA1 (15.2%), BAP1 (15.2%), KMT2C (15.2%), and ERCC2 (12.1%). TP53 mutations were rare (2/33; 6.1%), and Aviti resequencing confirmed the same two variants, with additional low-confidence calls excluded. Mutations were broadly distributed, enriched on chromosomes 1, 16, 7, 19, and 17. Conclusion: Ugandan MIUC displays a heterogeneous mutational profile, marked by frequent missense mutations, a high VUS burden, low TP53 frequency, and APOBEC signatures, with PDE4DIP a non-canonical gene emerging as the most frequently mutated. These findings underscore the need for African-specific genomic references to guide precision oncology.
Open AccessSomatic mutation profiles of muscle-invasive bladder cancer in Uganda: A cross-sectional study utilising whole-exome sequencing
Background: Muscle-invasive bladder cancer (MIBC) is a significant cause of cancer-related mortality in sub-Saharan Africa, yet its genomic landscape remains poorly characterised. In Uganda, nearly 60% of urothelial carcinoma cases are muscle-invasive (MIUC), with a near-equal sex distribution, in contrast to global trends. We aimed to define the somatic mutational landscape of Ugandan MIUC using whole-exome sequencing (WES). Methods: In this descriptive cross-sectional study, 57 formalin-fixed paraffin-embedded MIUC tissue blocks were consecutively selected. DNA extraction and exome library preparation were performed for all; 47 passed quality control and 33 remained in the final dataset. Sequencing was performed on the Illumina NovaSeq 6000 platform. Reads were aligned to hg19/GRCh37, and variants called using GATK Mutect2 in tumor-only mode with stringent artefact filters. Variants were annotated with COSMIC, ClinVar, REVEL, and classified according to ACMG/AMP guidelines. Eighteen samples were resequenced on the Aviti platform to validate the low frequency of TP53 mutations. Clinical and histopathological data were also reviewed. Results: All patients presented with gross hematuria, with a median age of 56 years; 17/33 (51.5%) were male. Histological variants occurred in 23/33 (69.7%), most commonly the squamous, microcystic, and nested types (each accounting for 5/23; 21.7%). LVI was present in 28/33 (84.8%). A total of 305 coding mutations were identified, averaging 9.2 ± 6.5 per tumor. Squamous and microcystic variants showed the highest burdens (16.4% and 14.4%). At the nucleotide level, 200/331 (60.4%) substitutions were C>T or C>G, consistent with APOBEC mutagenesis. Missense variants predominated (274/305; 89.8%), followed by frameshifts (31/305; 10.2%). PDE4DIP was the most frequent alteration (8/33; 24.2%), although it was not a canonical driver. Canonical recurrent drivers included FGFR3 (18.2%), FOXA1 (15.2%), BAP1 (15.2%), KMT2C (15.2%), and ERCC2 (12.1%). TP53 mutations were rare (2/33; 6.1%), and Aviti resequencing confirmed the same two variants, with additional low-confidence calls excluded. Mutations were broadly distributed, enriched on chromosomes 1, 16, 7, 19, and 17. Conclusion: Ugandan MIUC displays a heterogeneous mutational profile, marked by frequent missense mutations, a high VUS burden, low TP53 frequency, and APOBEC signatures, with PDE4DIP a non-canonical gene emerging as the most frequently mutated. These findings underscore the need for African-specific genomic references to guide precision oncology.
- 1 August 2025
- Published by Medpharm Publications in African Urology
- Vol. 5 (3) , 89-93
Expression patterns of EGFR, PD-L1, and Ki-67 among Ugandan patients with muscle-invasive bladder cancer
- 1 August 2025
- Published by Medpharm Publications in African Urology
- Vol. 5 (3) , 89-93
Expression patterns of EGFR, PD-L1, and Ki-67 among Ugandan patients with muscle-invasive bladder cancer
- 1 March 2025
- Published by Medpharm Publications in African Urology
- Vol. 5 (1) , 5-9
Unravelling bladder cancer in Uganda: insights from the discrepancies in TP53 assessment between immunohistochemistry and whole exome sequencing
- 1 March 2025
- Published by Medpharm Publications in African Urology
- Vol. 5 (1) , 5-9
Unravelling bladder cancer in Uganda: insights from the discrepancies in TP53 assessment between immunohistochemistry and whole exome sequencing
- Open Access
- 1 March 2024
- Published by Medpharm Publications in African Urology
- Vol. 4 (1) , 1-6
A histopathological study of bladder cancer in Uganda
Background: The incidence of squamous cell carcinoma (SCC) and adenocarcinoma of the bladder have been higher than that of urothelial carcinoma (UC) in several African countries for nearly five decades. However, this trend has changed over time, with ...
- 1 March 2024
- Published by Medpharm Publications in African Urology
- Vol. 4 (1) , 1-6
Open AccessA histopathological study of bladder cancer in Uganda
Background: The incidence of squamous cell carcinoma (SCC) and adenocarcinoma of the bladder have been higher than that of urothelial carcinoma (UC) in several African countries for nearly five decades. However, this trend has changed over time, with ...
- Open Access
- 5 December 2022
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 2 (12) , e0000870
Determinants of testing for HIV among young people in Uganda. A nested, explanatory-sequential study
Awareness of HIV serostatus helps individuals calibrate behaviour or link to care. Globally, young people (15-24years) contribute over 30% of new HIV infections. Despite progress in enhancing access to HIV services, HIV testing among young people in Uganda is below target. We determined the prevalence and factors influencing HIV testing among young people in a peri-urban district with the highest proportion of young people. We conducted a nested explanatory sequential mixed-methods study from March to May 2019 in Wakiso district. We used stratified cluster random sampling to select 397 rural and 253 urban young people from eight parishes. We collected data using questionnaires and subsequently conducted in-depth interviews with 16 purposively selected survey participants. The prevalence of testing for HIV was 80.2%. Young people related their decisions about HIV testing to self-evaluation of their risk and perceived ability to manage the consequences of a positive result. Participants reported high levels of support for HIV testing from peers, partners, and family members. They perceived health facilities as confusing, distant, expensive, and staffed by judgmental, older health workers as barriers. They felt that mobile testing points solved some of these problems, but introduced less privacy and greater confidentiality concerns. The prevalence of HIV testing among young people in Wakiso district was low compared to the UNAIDS 2030 target but among the highest in sub-Saharan Africa. Community-based programs resolve many concerns about testing at health facilities. However, there is a need to make these programs more comfortable and private.
- 5 December 2022
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 2 (12) , e0000870
Open AccessDeterminants of testing for HIV among young people in Uganda. A nested, explanatory-sequential study
Awareness of HIV serostatus helps individuals calibrate behaviour or link to care. Globally, young people (15-24years) contribute over 30% of new HIV infections. Despite progress in enhancing access to HIV services, HIV testing among young people in Uganda is below target. We determined the prevalence and factors influencing HIV testing among young people in a peri-urban district with the highest proportion of young people. We conducted a nested explanatory sequential mixed-methods study from March to May 2019 in Wakiso district. We used stratified cluster random sampling to select 397 rural and 253 urban young people from eight parishes. We collected data using questionnaires and subsequently conducted in-depth interviews with 16 purposively selected survey participants. The prevalence of testing for HIV was 80.2%. Young people related their decisions about HIV testing to self-evaluation of their risk and perceived ability to manage the consequences of a positive result. Participants reported high levels of support for HIV testing from peers, partners, and family members. They perceived health facilities as confusing, distant, expensive, and staffed by judgmental, older health workers as barriers. They felt that mobile testing points solved some of these problems, but introduced less privacy and greater confidentiality concerns. The prevalence of HIV testing among young people in Wakiso district was low compared to the UNAIDS 2030 target but among the highest in sub-Saharan Africa. Community-based programs resolve many concerns about testing at health facilities. However, there is a need to make these programs more comfortable and private.
- Open Access
- 9 March 2022
- Published by Springer Nature in BMC Public Health
- Vol. 22 (1) , 1-8
Factors associated with willingness to use oral pre-exposure prophylaxis (PrEP) in a fisher-folk community in peri-urban Kampala, Uganda
Background: The World Health Organization (WHO) recommends the use of pre-exposure prophylaxis (PrEP) in key populations at elevated risk for exposure to HIV. If used effectively, PrEP can reduce annual HIV incidence to below 0.05%. However, PrEP is not acceptable among all communities that might benefit from it. There is, therefore, a need to understand perceptions of PrEP and factors associated with willingness to use PrEP among key populations at risk of HIV, such as members of communities with exceptionally high HIV prevalence. Objective: To examine the perceptions and factors associated with willingness to use oral PrEP among members of fishing communities in Uganda, a key population at risk of HIV. Methods: We conducted an explanatory sequential mixed-methods study at Ggaba fishing community from February to June 2019. Survey data were collected from a systematic random sample of 283 community members in which PrEP had not been rolled out yet by the time of we conducted the study. We carried out bivariate tests of association of willingness to use PrEP with demographic characteristics, HIV risk perception, HIV testing history. We estimated prevalence ratios for willingness to use PrEP. We used backward elimination to build a multivariable modified Poisson regression model to describe factors associated with willingness to use PrEP. We purposively selected 16 participants for focus group discussions to contextualize survey findings, analysing data inductively and identifying emergent themes related to perceptions of PrEP. Key results: We enrolled 283 participants with a mean age of 31 ± 8 years. Most (80.9%) were male. The majority of participants had tested for HIV in their lifetime, but 64% had not tested in the past 6 months. Self-reported HIV prevalence was 6.4%. Most (80.6, 95%CI 75.5–85.0) were willing in principle to use PrEP. Willingness to use PrEP was associated with perceiving oneself to be at high risk of HIV (aPR 1.99, 95%CI 1.31–3.02, P = 0.001), having tested for HIV in the past 6-months (aPR 1.13, 95%CI 1.03–1.24, P = 0.007), and completion of tertiary education (aPR 1.97, 95%CI 1.39–2.81, P < 0.001). In focus group discussions, participants described pill burden, side-effects and drug safety as potential barriers to PrEP use. Conclusions and recommendations: Oral PrEP was widely acceptable among members of fishing communities in peri-urban Kampala. Programs for scaling-up PrEP for fisherfolk should merge HIV testing services with sensitization about PrEP and also increase means of awareness of PrEP as an HIV preventive strategy .
- 9 March 2022
- Published by Springer Nature in BMC Public Health
- Vol. 22 (1) , 1-8
Open AccessFactors associated with willingness to use oral pre-exposure prophylaxis (PrEP) in a fisher-folk community in peri-urban Kampala, Uganda
Background: The World Health Organization (WHO) recommends the use of pre-exposure prophylaxis (PrEP) in key populations at elevated risk for exposure to HIV. If used effectively, PrEP can reduce annual HIV incidence to below 0.05%. However, PrEP is not acceptable among all communities that might benefit from it. There is, therefore, a need to understand perceptions of PrEP and factors associated with willingness to use PrEP among key populations at risk of HIV, such as members of communities with exceptionally high HIV prevalence. Objective: To examine the perceptions and factors associated with willingness to use oral PrEP among members of fishing communities in Uganda, a key population at risk of HIV. Methods: We conducted an explanatory sequential mixed-methods study at Ggaba fishing community from February to June 2019. Survey data were collected from a systematic random sample of 283 community members in which PrEP had not been rolled out yet by the time of we conducted the study. We carried out bivariate tests of association of willingness to use PrEP with demographic characteristics, HIV risk perception, HIV testing history. We estimated prevalence ratios for willingness to use PrEP. We used backward elimination to build a multivariable modified Poisson regression model to describe factors associated with willingness to use PrEP. We purposively selected 16 participants for focus group discussions to contextualize survey findings, analysing data inductively and identifying emergent themes related to perceptions of PrEP. Key results: We enrolled 283 participants with a mean age of 31 ± 8 years. Most (80.9%) were male. The majority of participants had tested for HIV in their lifetime, but 64% had not tested in the past 6 months. Self-reported HIV prevalence was 6.4%. Most (80.6, 95%CI 75.5–85.0) were willing in principle to use PrEP. Willingness to use PrEP was associated with perceiving oneself to be at high risk of HIV (aPR 1.99, 95%CI 1.31–3.02, P = 0.001), having tested for HIV in the past 6-months (aPR 1.13, 95%CI 1.03–1.24, P = 0.007), and completion of tertiary education (aPR 1.97, 95%CI 1.39–2.81, P < 0.001). In focus group discussions, participants described pill burden, side-effects and drug safety as potential barriers to PrEP use. Conclusions and recommendations: Oral PrEP was widely acceptable among members of fishing communities in peri-urban Kampala. Programs for scaling-up PrEP for fisherfolk should merge HIV testing services with sensitization about PrEP and also increase means of awareness of PrEP as an HIV preventive strategy .
- Open Access
- 11 March 2021
- Published by Springer Nature in Research Square
Factors Associated With Willingness to Use Oral Pre-exposure Prophylaxis (Prep) Among Fishing Communities in Peri-urban Kampala, Uganda
Background: The World Health Organization (WHO) recommends the use of pre-exposure prophylaxis (PrEP) in key populations at elevated risk for exposure to HIV. If used effectively, PrEP can reduce annual HIV incidence to below 0.05%. However, PrEP is not acceptable among all communities that might benefit from it. There is, therefore, a need to understand perceptions of PrEP and factors associated with willingness to use PrEP among key populations at risk of HIV, such as members of communities with exceptionally high HIV prevalence. Objective: To examine the perceptions and factors associated with willingness to use oral PrEP among members of fishing communities in Uganda, a key population at risk of HIV. Methods: We conducted an explanatory sequential mixed-methods study at Ggaba fishing community from February to June 2019. Survey data were collected from a systematic random sample of 283 community members. We carried out bivariate tests of association of willingness to use PrEP with demographic characteristics, HIV risk perception, HIV testing history. We estimated prevalence ratios for willingness to use PrEP. We used backward elimination to build a multivariable modified Poisson regression model to describe factors associated with willingness to use PrEP. We purposively selected 16 participants for focus group discussions to contextualize survey findings, analysing data inductively and identifying emergent themes related to perceptions of PrEP. Key results: We enrolled 283 participants with a mean age of 31±8 years. Most (80.9%) were male. The majority of participants had tested for HIV in their lifetime, but 64% had not tested in the past 6 months. Self-reported HIV prevalence was 6.4%. Most (80.6%, 95%CI 75.5-85.0) were willing in principle to use PrEP. Willingness to use PrEP was associated with perceiving oneself to be at high risk of HIV (aPR 1.99, 95%CI 1.31-3.02, P= 0.001), having tested for HIV in the past 6-months (aPR 1.13, 95%CI 1.03-1.24, P=0.007), and completion of tertiary education (aPR 1.97, 95%CI 1.39-2.81, PConclusions and recommendations: Oral PrEP was widely acceptable among members of fishing communities in peri-urban Kampala. Programs for scaling-up PrEP for fisherfolk should merge HIV testing services with sensitization about PrEP and also address issues of access to drugs.
- 11 March 2021
- Published by Springer Nature in Research Square
Open AccessFactors Associated With Willingness to Use Oral Pre-exposure Prophylaxis (Prep) Among Fishing Communities in Peri-urban Kampala, Uganda
Background: The World Health Organization (WHO) recommends the use of pre-exposure prophylaxis (PrEP) in key populations at elevated risk for exposure to HIV. If used effectively, PrEP can reduce annual HIV incidence to below 0.05%. However, PrEP is not acceptable among all communities that might benefit from it. There is, therefore, a need to understand perceptions of PrEP and factors associated with willingness to use PrEP among key populations at risk of HIV, such as members of communities with exceptionally high HIV prevalence. Objective: To examine the perceptions and factors associated with willingness to use oral PrEP among members of fishing communities in Uganda, a key population at risk of HIV. Methods: We conducted an explanatory sequential mixed-methods study at Ggaba fishing community from February to June 2019. Survey data were collected from a systematic random sample of 283 community members. We carried out bivariate tests of association of willingness to use PrEP with demographic characteristics, HIV risk perception, HIV testing history. We estimated prevalence ratios for willingness to use PrEP. We used backward elimination to build a multivariable modified Poisson regression model to describe factors associated with willingness to use PrEP. We purposively selected 16 participants for focus group discussions to contextualize survey findings, analysing data inductively and identifying emergent themes related to perceptions of PrEP. Key results: We enrolled 283 participants with a mean age of 31±8 years. Most (80.9%) were male. The majority of participants had tested for HIV in their lifetime, but 64% had not tested in the past 6 months. Self-reported HIV prevalence was 6.4%. Most (80.6%, 95%CI 75.5-85.0) were willing in principle to use PrEP. Willingness to use PrEP was associated with perceiving oneself to be at high risk of HIV (aPR 1.99, 95%CI 1.31-3.02, P= 0.001), having tested for HIV in the past 6-months (aPR 1.13, 95%CI 1.03-1.24, P=0.007), and completion of tertiary education (aPR 1.97, 95%CI 1.39-2.81, PConclusions and recommendations: Oral PrEP was widely acceptable among members of fishing communities in peri-urban Kampala. Programs for scaling-up PrEP for fisherfolk should merge HIV testing services with sensitization about PrEP and also address issues of access to drugs.
- Open Access
- 22 January 2021
- Published by Springer Nature in BMC Ophthalmology
- Vol. 21 (1) , 1-7
Prevalence and predictors of ocular complications among children undergoing nephrotic syndrome treatment in a resource-limited setting
Nephrotic syndrome is the most common glomerulopathy among children aged 2–18 years and high dose corticosteroids are the backbone of its management. Potentially blinding ocular complications often result from nephrotic syndrome and/or its treatment. We conducted a study to determine the prevalence and predictors of ocular complications among children undergoing nephrotic syndrome treatment at Mulago National Referral Hospital. This was a cross-sectional study conducted for three [3] months at the pediatric renal unit of Mulago National Referral Hospital (MNRH). Data from a consecutive sample of 100 children was collected using a semi-structured questionnaire, entered into Epi-data 4.4.2 and exported to STATA 14 for analysis at univariate, bivariate and multivariate levels. A robust Poisson regression model was used to identify predictors of ocular complications. Out of 100 patients examined, 80(80%) had ocular complications. The median age was 10 (IQR: 7–12) and 52 (52%) were girls. The most frequent complications were hypertrichosis and refractive errors in 71% (95%CI 61.1–79.6) and 56% (95%CI 45.7–65.9) of the patients respectively. Age above 10 years was the predictor for ocular complications with a RR = 1.37 (95%CI:1.14–1.64) p = 0.001. We found a high prevalence of ocular complications among children with nephrotic syndrome in this tertiary hospital. The predictor of ocular complications was age greater than 10 years. We recommend that all children with nephrotic syndrome undergo a baseline ocular examination prior to commencement of treatment and be reviewed periodically by an ophthalmologist.
- 22 January 2021
- Published by Springer Nature in BMC Ophthalmology
- Vol. 21 (1) , 1-7
Open AccessPrevalence and predictors of ocular complications among children undergoing nephrotic syndrome treatment in a resource-limited setting
Nephrotic syndrome is the most common glomerulopathy among children aged 2–18 years and high dose corticosteroids are the backbone of its management. Potentially blinding ocular complications often result from nephrotic syndrome and/or its treatment. We conducted a study to determine the prevalence and predictors of ocular complications among children undergoing nephrotic syndrome treatment at Mulago National Referral Hospital. This was a cross-sectional study conducted for three [3] months at the pediatric renal unit of Mulago National Referral Hospital (MNRH). Data from a consecutive sample of 100 children was collected using a semi-structured questionnaire, entered into Epi-data 4.4.2 and exported to STATA 14 for analysis at univariate, bivariate and multivariate levels. A robust Poisson regression model was used to identify predictors of ocular complications. Out of 100 patients examined, 80(80%) had ocular complications. The median age was 10 (IQR: 7–12) and 52 (52%) were girls. The most frequent complications were hypertrichosis and refractive errors in 71% (95%CI 61.1–79.6) and 56% (95%CI 45.7–65.9) of the patients respectively. Age above 10 years was the predictor for ocular complications with a RR = 1.37 (95%CI:1.14–1.64) p = 0.001. We found a high prevalence of ocular complications among children with nephrotic syndrome in this tertiary hospital. The predictor of ocular complications was age greater than 10 years. We recommend that all children with nephrotic syndrome undergo a baseline ocular examination prior to commencement of treatment and be reviewed periodically by an ophthalmologist.